Can hydralazine be used with Angiotensin-Converting Enzyme (ACE) inhibitor and metoprolol to wean off nitroglycerin drip in resolving hypertensive emergency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hydralazine can be used alongside an ACE inhibitor and metoprolol to wean a patient off a nitroglycerin drip during resolution of a hypertensive emergency, as evidenced by the most recent guideline recommendations 1. This combination approach is often effective because it targets different blood pressure control mechanisms. Hydralazine is a direct vasodilator that can help maintain blood pressure control as the nitroglycerin is gradually reduced. When implementing this strategy, start with small doses of oral hydralazine (10-25 mg every 6-8 hours) while carefully monitoring blood pressure. The ACE inhibitor provides longer-term blood pressure management by affecting the renin-angiotensin-aldosterone system, while metoprolol, a beta-blocker, reduces heart rate and cardiac output. This multi-drug approach allows for a smoother transition from IV to oral therapy by addressing different physiological pathways of blood pressure control. However, careful monitoring is essential as the combination can potentially cause excessive hypotension. Blood pressure and heart rate should be checked frequently during the weaning process, and medication doses may need adjustment based on the patient's response. Renal function should also be monitored, particularly with the ACE inhibitor component of the regimen, as noted in the guidelines 1. Key considerations include:

  • Starting with low doses of hydralazine and titrating as needed
  • Monitoring for signs of excessive hypotension or other adverse effects
  • Adjusting medication doses based on patient response and clinical status
  • Considering the use of alternative agents if necessary, as outlined in the guidelines 1.

From the Research

Hypertensive Emergency Management

The management of hypertensive emergencies involves the use of intravenous antihypertensive agents to rapidly lower blood pressure and prevent target-organ damage. According to 2, agents such as sodium nitroprusside, nitroglycerin, and hydralazine have been used for many years as first-line options for patients with hypertensive emergencies.

Weaning Off Nitroglycerin Drip

To wean off a nitroglycerin drip, a combination of antihypertensive agents may be used. The following points should be considered:

  • Hydralazine can be used in combination with other antihypertensive agents, such as ACE inhibitors and beta blockers, to manage hypertensive emergencies 3.
  • ACE inhibitors, such as enalaprilat, may be beneficial in patients with impaired cerebral circulation 3.
  • Beta blockers, such as metoprolol, can be used to control heart rate and blood pressure in patients with hypertensive emergencies 4, 5.
  • The choice of antihypertensive therapy regimen should be based on the underlying end-organ damage and the patient's clinical condition 4.

Key Considerations

When using a combination of antihypertensive agents to wean off a nitroglycerin drip, the following key considerations should be kept in mind:

  • The goal is to gradually reduce blood pressure to a safe level, avoiding overly rapid reductions that can lead to reduced blood flow to the central nervous system 4, 5.
  • Close monitoring of blood pressure and clinical condition is essential to adjust the antihypertensive therapy regimen as needed 2, 4, 5.
  • The use of oral antihypertensive agents, such as ACE inhibitors, may be considered for the long-term management of hypertensive patients 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of hypertensive urgencies and emergencies.

Journal of clinical pharmacology, 1995

Research

[The hypertensive emergency situation : Recommendations for initial drug therapy management].

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2022

Research

Hypertensive emergencies.

Emergency medicine clinics of North America, 1995

Research

Oral drugs for hypertensive urgencies: systematic review and meta-analysis.

Sao Paulo medical journal = Revista paulista de medicina, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.